CompletedPhase 4ACTRN12611000384954

Providac techsules for prevention of Antibiotic-Associated Diarrhea

Randomized placebo-controlled, double blind, Multicentric Trial on Efficacy and Safety of Providac techsules (Lactobacillus acidophilus LA-5 and Bifidobacterium BB -12) for prevention of Antibiotic-Associated Diarrhea in Indian patients


Sponsor

Zydus Alidac,Cadila Healthcare Limited,

Enrollment

400 participants

Start Date

Feb 3, 2010

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This trial tests whether taking a probiotic supplement (Providac) alongside antibiotics can prevent antibiotic-associated diarrhoea. It is for adults aged 18-70 who are prescribed oral antibiotics (cefadroxil or amoxicillin) for at least 5 days and are otherwise generally healthy.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Orally administered Providac capsules (Lactobacillus acidophilus LA5, 500 million Colony Forming Units & Bifidobacterium BB12, 500 million Colony Forming Units) twice daily or placebo treatment, tak

Orally administered Providac capsules (Lactobacillus acidophilus LA5, 500 million Colony Forming Units & Bifidobacterium BB12, 500 million Colony Forming Units) twice daily or placebo treatment, taken twice daily (alongwith antibiotic therapy commencement) after food for 14 days and followed up during this period of 14 days (at day 7 and day 14 following study medication commencement). A special name assigned to specially designed capsules-Techsules. These are Technologically innovated capsules that ensure targeted delivery of probiotics.


Locations(1)

India

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000384954